| Revenue growth | 8% YoY to ₹48.9 Cr |
|---|---|
| Margins | EBITDA margin 28.9% vs 38.2%; PAT margin 16.0% vs 22.2% |
| Demand visibility | 150+ B2B tie-ups; three PPP projects pending MOU signing |
Growth
Revenue +8% YoY to ₹48.9 Cr; B2C +21%, B2B +20%, B2G -1%. Radiology +6%, pathology +17%.
Outlook
FY27 capex ₹20-25 Cr; Dwarka centre due end-November (PCPNDT approval pending, ₹5-6 Cr initial revenue); three PPP projects in pipeline.
Risks
EBITDA margin down 936 bps to 28.9%; operating cash flow negative at ₹(6.2) Cr; receivables up to ₹64.0 Cr; opex up 23%.
Investor Presentation filed with BSE, BSE: 544482. Summary written with AI assistance from the document.
Star Imaging and Path Lab Ltd: key numbers
- Share price
- ₹63.40
- Market cap
- ₹110.4 Cr
- Revenue (annual)
- ₹88.53 Cr
- Net profit (annual)
- ₹19.28 Cr
- P/E (TTM)
- 5.7×Sector 56.7×
- Promoter holding
- 71.92%
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Imaging and Path Lab Ltd
All →Star Imaging and Path Lab Partnership
Star Imaging and Path Lab entered an MoU with BSES Yamuna Power for empanelment as a designated diagnostic centre, valid to 31 December 2027. Services are provided at CGHS rates with no stated contract value.
- Execution
- Valid up to 31 December 2027
Star Imaging and Path Lab Other Announcement
Star Imaging filed its final IPO proceeds monitoring report for the quarter ended September 30, 2026. It confirms full utilisation with no deviation from stated objects.
Star Imaging and Path Lab H1 FY27 Results: Net Profit ₹7.8 Cr, Down 22.8% YoY
Star Imaging and Path Lab Ltd reported revenue from operations of ₹48.9 Cr (+8.2% YoY) and net profit of ₹7.8 Cr (-22.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹7.8 Cr · -22.8% YoY
Star Imaging and Path Lab Board Meeting Date
Star Imaging And Path Lab Ltd intimated a board meeting on 13 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. Trading window closed from 1 October 2026 to 15 November 2026.
Star Imaging and Path Lab Business Update
Star Imaging and Path Lab has been empanelled with the Municipal Corporation of Delhi to provide diagnostic services at CGHS rates.
- From
- Municipal Corporation of Delhi (MCD)
Star Imaging and Path Lab Other Announcement
Star Imaging And Path Lab Ltd has submitted its shareholding pattern for the quarter ended September 30, 2026. The filing provides details of equity shareholdings.